Orchestra BioMed Holdings, Inc.
OBIONasdaqCIK 1814114HealthcareFiscal year ends Dec 31
Reports and events: 91 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0112:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-112586 |
| 2026-09-0813:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-105733 |
| 2026-08-1020:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-093357 |
| 2026-06-2320:52 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-076845 |
| 2026-05-1220:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059382 |
| 2026-04-2921:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493215-26-000068 |
| 2026-04-2920:30 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001104659-26-051570 |
| 2026-03-1212:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-026754 |
| 2026-02-2521:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493215-26-000063 |
| 2026-02-1322:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-015315 |
| 2026-01-1214:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002752 |
| 2025-11-1313:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-110907 |
| 2025-11-1021:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-109128 |
| 2025-10-3011:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-104016 |
| 2025-10-2812:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-102862 |
| 2025-08-1212:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011148 |
| 2025-08-0620:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-021175 |
| 2025-08-0420:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-073641 |
| 2025-07-3120:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-072678 |
| 2025-06-2420:14 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-062105 |
| 2025-05-1220:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007373 |
| 2025-05-0121:41 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-062060 |
| 2025-04-3020:16 ET | DEF 14A | Proxy statementPeriod 2025-06-24 | 0001104659-25-042530 |
| 2025-04-2913:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-040763 |
| 2025-03-3120:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-004161 |
| 2025-03-0313:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-019500 |
| 2025-02-2521:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-016950 |
| 2025-02-0513:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-009393 |
| 2024-11-1221:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015313 |
| 2024-08-1221:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-088431 |
| 2024-08-1220:11 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011899 |
| 2024-08-0721:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-196045 |
| 2024-08-0721:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-196038 |
| 2024-07-3020:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-083973 |
| 2024-06-2020:44 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-073435 |
| 2024-06-1112:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-070204 |
| 2024-05-1320:38 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007978 |
| 2024-04-3020:16 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001104659-24-054945 |
| 2024-03-2920:44 ET | 8-K | 8.01 Other events | 0001104659-24-041173 |
| 2024-03-2720:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-004083 |
| 2024-03-0700:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-031605 |
| 2023-11-2800:03 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-121331 |
| 2023-11-1411:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-117492 |
| 2023-11-1321:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018829 |
| 2023-10-1021:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-108359 |
| 2023-10-1021:07 ET | S-1 | Registration statement | 0001104659-23-108348 |
| 2023-09-1911:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-101763 |
| 2023-08-1020:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-014496 |
| 2023-07-1301:36 ET | 8-K/A | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-080462 |
| 2023-07-1213:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-080208 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.